Fact CheckerSign in

NCT07343375Enrolling by invitation

Effect of High-intensity Interval Training on the Lung in Patients With COPD Referred for Lung Volume Reduction Surgery: The PREGENERATE Trial

Source: ClinicalTrials.gov · Last updated 2 Apr 2026

Brief summary (registry, in English)

Patients with chronic obstructive lung disease (COPD) suffer from a progressive loss of lung function that leads to poor quality of life, and often invalidity and early death. Regular exercise can improve quality of life in these patients, but there is a lack in understanding the underlying mechanism of exercise-induced improvement in COPD and it is widely thought not to have any effect on the lung as such. In the present study, the investigators aim to investigate the impact of an extensive high-intensity interval training (HIIT)-based exercise scheme on the regenerative capacity of the lung in patients with COPD on waiting list for lung volume reduction surgery. Design: Prospective randomized controlled clinical trial. Intervention: 24 persons with COPD referred for lung volume reduction surgery will randomly be allocated (1:1) to prehabilitation with high intensity interval training (HIIT) or non-exercise control. Outcomes: The primary outcome is differences in change in differential protein composition in distal lung tissue between HIIT and control groups post-intervention using spatial multimodal proteomics. Furthermore, lung tissue mass, protein composition (mass spectrometry and spatial omics e.g. MACSima), pulmonary blood volume, blood protein profile (biomarkers), diffusion capacity at rest and during exercise, oxygen consumption tests, body composition scan, distal airspace radii and physical functional tests will be measured before and after the intervention. Perspective: This study may fundamentally change the view on the regenerative potential of the lungs in COPD.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
24 (estimated)
First submitted
8 Dec 2025
Start date
Apr 2026
Primary completion date
Jan 2029
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
Diseases
COPD
NCT number
NCT07343375

What you commit to

  • Study type: Interventional
  • Planned participants: 24
  • From Apr 2026 to the primary completion date, Jan 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Symptoms of acute disease within 2 weeks prior to the study

Other illness

  • Symptoms of ischaemic heart disease
  • Known heart failure
  • Known malignant disease
  • Unstable cardiac arrhythmic disease

Lab values

  • Renal or liver dysfunction
    • Known chronic kidney or liver disease
    • Elevated creatinine, urea, alanine transaminase (ALAT), aspartate transaminase (ASAT), bilirubin, basic phosphatases at blood test

Other

  • Unable to complete or understand HIIT training
  • Claudication
  • Pregnancy

Who the study is looking for

  • Men and women
  • Referred for lung volume reduction surgery at Rigshospitalet because of emphysematous COPD.

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centre for Physical Activity Research, Copenhagen University Hospital
Coordinator of this site? Confirm its status
CopenhagenDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.